Sabra Health Care: Pivoting To Win From An Unstoppable Demographic Tailwind

Sabra Health Care REIT remains a Buy, driven by its aggressive pivot into the Seniors Housing Operating Portfolio model. SBRA's SHOP transition offers direct exposure to demographic tailwinds from the 'Silver Tsunami,' positioning for significant potential occupancy and AFFO growth. Q1 results were strong, with AFFO at $0.39/share, nearly reaching the annual investment target, and a 77% dividend payout ratio supporting a ~6% yield. Despite near-term macro headwinds and increased operational risk, SBRA's intrinsic value estimate of $23.41/share implies re-rating potential above current levels.